Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Ocuphire Pharma, Inc. | ex32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - Ocuphire Pharma, Inc. | ex31_1.htm |
| EX-24.1 - EXHIBIT 24.1 - Ocuphire Pharma, Inc. | ex24_1.htm |
| EX-4.9 - EXHIBIT 4.9 - Ocuphire Pharma, Inc. | ex4_9.htm |
| 10-K - 10-K - Ocuphire Pharma, Inc. | form10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-218285) and Form S-8 (File No. 333-189240, 333-129294 and
333-217627) of Rexahn Pharmaceuticals, Inc., of our report dated February 21, 2020, relating to the financial statements of Rexahn Pharmaceuticals, Inc. which appear in this Annual Report on Form 10- K for the year ended December 31, 2019.
|
/s/ BAKER TILLY VIRCHOW KRAUSE, LLP
|
|
Lancaster, Pennsylvania
|
|
February 21, 2020
|